Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance
CNBCarrow_outwardNovo appoints new CEO as it slashes profit forecast
Financial Timesarrow_outwardObesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook
Yahoo Financearrow_outwardNvo Stock Plummets 20% as Novo Nordisk Lowers Guidance Amid Rising Weight-Loss Drug Competition - AInvest
AInvestarrow_outwardNovo Nordisk stock drops after guidance cut (NVO:NYSE) - Seeking Alpha
Seeking Alphaarrow_outward3 Surprisingly Underrated Stocks to Buy Right Now - The Motley Fool
The Motley Foolarrow_outwardHere's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 5 Years - 富途牛牛
富途牛牛arrow_outwardHere's Why Novo Nordisk (NVO) is a Strong Value Stock - Nasdaq
Nasdaqarrow_outwardNovo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (July 2025) - 24/7 Wall St.
24/7 Wall St.arrow_outwardIs Hims & Hers Stock in Trouble? - The Globe and Mail
The Globe and Mailarrow_outward12 Stocks That Will Make You Rich in 10 Years - Insider Monkey
Insider Monkeyarrow_outwardNovo Nordisk Stock Sinks as Latest Weight-Loss Drug Trial Disappoints - Investopedia
Investopediaarrow_outwardNovo Nordisk, Hims and Hers Shares Tumble on Severed Ties - Schaeffer's Investment Research
Schaeffer's Investment Researcharrow_outwardACC Endorsement Boosts Novo Nordisk (NVO) Stock - GuruFocus
GuruFocusarrow_outwardNovo Nordisk Is Teaming Up With Nvidia. Should You Buy NVO Stock Now? - Barchart.com
Barchart.comarrow_outward(NVO) Stock Trading Blueprint (NVO:CA) - news.stocktradersdaily.com
News.stocktradersdaily.comarrow_outwardNVO Stock Gains After Parvus Asset Management Builds Stake - Zacks Investment Research
Zacks Investment Researcharrow_outwardNovo Nordisk Stock (NVO) Shakes off Links Between Weight Jabs and Vision Loss - TipRanks
TipRanksarrow_outwardBMO maintains Novo Nordisk stock at market perform, $64 target - Investing.com
Investing.comarrow_outwardIs It Time to Buy the Dip in Novo Nordisk Stock? - MarketBeat
MarketBeatarrow_outwardSepterna stock pops on partnership with Novo Nordisk to develop obesity therapies | NYSE:NVO - Proactive financial news
Proactive financial newsarrow_outwardShould You Buy The Current Dip In Novo Nordisk Stock? - Forbes
Forbesarrow_outwardIs Novo Nordisk Stock a Buy After its Collapse? - Morningstar
Morningstararrow_outwardNovo Nordisk Down 15% in March: Is This a Buying Opportunity? - TradingView
TradingViewarrow_outward
Nvo Stock close
- 2025-07-29 20:30 event
- 24 sourceslanguage
- 200+ ads_click
- 5 days ago schedule